Xcout IntelSign inSubscribe

Egalet Corp competitors & alternatives

PharmaceuticalsUnited States

The 12 closest competitors and alternatives to Egalet Corp among pharmaceuticals companies — ranked by similarity to what Egalet Corp actually does, not by market-cap band.

12Competitors listed

Subscribe to see Egalet Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Egalet Corp

Egalet Corporation is a fully integrated specialty pharmaceutical company headquartered in Pennsylvania focused on developing, manufacturing, and commercializing treatments.

Egalet Corp at a glance

Egalet Corp is a pharmaceuticals company headquartered in United States. It has raised at least $56.5M across the 2 funding rounds on record. Its most recent funding round raised $42.2M in January 2019. Xcout tracks 5 named people at Egalet Corp, including Robert Radie (President and Chief Executive Officer and Member of our Board of Directors).

Egalet Corp leadership

  • Robert RadiePresident and Chief Executive Officer and Member of our Board of Directors
  • Jean-Francois FormelaChairman
  • Gregory WeaverMember of our Board of Directors
  • Renee Aguiar-LucanderMember of our Board of Directors
  • Timothy WalbertMember of our Board of Directors

Egalet Corp funding rounds

At least $56.5M raised across the 2 rounds on record. Every round on record:

DateRoundAmountInvestors
SEC Form D filing$42.2M—
Series B$14.3M1 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 Egalet Corp competitors

Ranked by semantic similarity — how close each company is to Egalet Corp by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

ELITE PHARMACEUTICALS INC /NV/ELTP · PharmaceuticalsNorthvale, United States
67% matchPublic

Similar pharmaceuticals company

Elite Pharmaceuticals, Inc. (ELTP) is a specialized pharmaceutical company focused on the creation and manufacturing of generic medications, as well as oral, controlled-release drug formulations. Its business activities are primarily divided into two segments: Abbreviated New Drug Applications (ANDAs) for generic products and New Drug Applications (NDAs) for branded pharmaceuticals. The company's extensive product line includes drugs that it either owns, licenses, or produces through contract manufacturing. This portfolio features a variety of generic and oral-dose pharmaceutical products designed to address diverse medical needs. For instance, it offers Phentermine HCl 37.5mg tablets, marketed under the Adipex-P brand, and Phendimetrazine Tartrate 35mg tablets, known as Bontril, both utilized in bariatric medicine. Its offerings also extend to Naltrexone HCl 50mg tablets (Revia brand) for pain management, and Isradipine 2.5mg and 5mg capsules for cardiovascular conditions. Elite Pharmaceuticals further supplies various strengths of Oxycodone HCl immediate release tablets (5mg, 10mg, 15mg, 20mg, and 30mg) under the Roxycodone brand for pain relief, as well as Trimipramine Maleate Immediate Release antidepressant capsules (Surmontil brand). For central nervous system disorders, the company provides Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets, commonly associated with the Adderall brand. Additionally, its products include Dantrolene Sodium capsules (Dantrium brand) for muscle relaxation, SequestOX (an immediate-release Oxycodone formulation combined with Naltrexone), Loxapine Succinate capsules (Loxapine brand) for antipsychotic treatment, and a combination of Acetaminophen and Codeine Phosphate for managing mild to moderate pain, alongside various antibiotic products. Beyond its own product portfolio, Elite Pharmaceuticals also undertakes contract manufacturing of controlled-release products for external parties, covering therapeutic areas such as pain, allergies, bariatrics, and infections. The company is actively engaged in developing a new generation of opioid products specifically engineered to deter abuse. Established in 1997, Elite Pharmaceuticals, Inc. maintains its corporate headquarters in Northvale, New Jersey.

Market cap$280.1M
Employees64
ELITE PHARMACEUTICALS INC /NV/ competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Egalet Corp and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Egalet Corpand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →